Epilepsy surgery in infants up to 3 months of age: Safety, feasibility, and outcomes: A multicenter, multinational study

Summary Objective Drug‐resistant epilepsy (DRE) during the first few months of life is challenging and necessitates aggressive treatment, including surgery. Because the most common causes of DRE in infancy are related to extensive developmental anomalies, surgery often entails extensive tissue resec...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsia (Copenhagen) 2021-08, Vol.62 (8), p.1897-1906
Main Authors: Roth, Jonathan, Constantini, Shlomi, Ekstein, Margaret, Weiner, Howard L., Tripathi, Manjari, Chandra, Poodipedi Sarat, Cossu, Massimo, Rizzi, Michele, Bollo, Robert J., Machado, Hélio Rubens, Santos, Marcelo Volpon, Keating, Robert F., Oluigbo, Chima O., Rutka, James T., Drake, James M., Jallo, George I., Shimony, Nir, Treiber, Jeffrey M., Consales, Alessandro, Mangano, Francesco T., Wisoff, Jeffrey H., Teresa Hidalgo, Eveline, Bingaman, William E., Gupta, Ajay, Erdemir, Gozde, Sundar, Swetha J., Benifla, Mony, Shapira, Vladimir, Lam, Sandi K., Fallah, Aria, Maniquis, Cassia A. B., Tisdall, Martin, Chari, Aswin, Cinalli, Giuseppe, Blount, Jeffrey P., Dorfmüller, Georg, Christine Bulteau, Uliel‐Sibony, Shimrit
Format: Article
Language:English
Subjects:
Age
Aged
Drug Resistant Epilepsy - surgery
Dysplasia
Electroencephalography
Epilepsy
Epilepsy - surgery
Feasibility Studies
hemispherotomy
Humans
Hydrocephalus
Infant
Infants
Malformations of Cortical Development
Morbidity
neonatal seizures
Patients
Retrospective Studies
Safety
seizure control
Seizures
Surgery
Treatment Outcome
Tubers
very early
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Objective Drug‐resistant epilepsy (DRE) during the first few months of life is challenging and necessitates aggressive treatment, including surgery. Because the most common causes of DRE in infancy are related to extensive developmental anomalies, surgery often entails extensive tissue resections or disconnection. The literature on “ultra‐early” epilepsy surgery is sparse, with limited data concerning efficacy controlling the seizures, and safety. The current study's goal is to review the safety and efficacy of ultra‐early epilepsy surgery performed before the age of 3 months. Methods To achieve a large sample size and external validity, a multinational, multicenter retrospective study was performed, focusing on epilepsy surgery for infants younger than 3 months of age. Collected data included epilepsy characteristics, surgical details, epilepsy outcome, and complications. Results Sixty‐four patients underwent 69 surgeries before the age of 3 months. The most common pathologies were cortical dysplasia (28), hemimegalencephaly (17), and tubers (5). The most common procedures were hemispheric surgeries (48 procedures). Two cases were intentionally staged, and one was unexpectedly aborted. Nearly all patients received blood products. There were no perioperative deaths and no major unexpected permanent morbidities. Twenty‐five percent of patients undergoing hemispheric surgeries developed hydrocephalus. Excellent epilepsy outcome (International League Against Epilepsy [ILAE] grade I) was achieved in 66% of cases over a median follow‐up of 41 months (19–104 interquartile range [IQR]). The number of antiseizure medications was significantly reduced (median 2 drugs, 1–3 IQR, p 
ISSN:0013-9580
1528-1167
DOI:10.1111/epi.16959